BioSpace News Archive

Amarin Corporation plc (NASDAQ:AMRN), today announced that eight presentations, including one Late-Breaking Science presentation and seven poster presentations, relevant to VASCEPA® (icosapent ethyl) and persistent cardiovascular risk (P-CVR), will be presented at the American College of Cardiology’s 69th Annual Scientific Session Together With World Congress of Cardiology (ACC.20/WCC), between March 28-30.

Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported financial results for the fourth quarter and full year ended December 31, 2019.

Beyond Air, Inc. announced submission of an Investigational Device Exemption to the U.S. Food and Drug Administration for use of its LungFitTM BRO system in the treatment of COVID-19 patients.

Clarus Therapeutics, Inc., a commercial men’s health specialty pharmaceutical company, announced today that it has completed a senior debt financing of up to $75M. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended December 31, 2019.

Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico, today announced that Amy Langer has resigned from the Board of Directors in order to focus on her other business endeavors.

INVO’s novel, FDA-cleared INVOcell technology provides an in-vivo incubation solution which can help increase access and capacity to the large underserved global fertility market

Digital health and supply chain entrepreneurs Randy Parker and Glenn Nussdorf today announced the launch of Genius Rx, a full-service, fully automated digital pharmacy that will use proprietary technology to make pharmacy services simple, intuitive and personal for consumers.

Bridge Medicines and The Rockefeller University today announced an exclusive license agreement to develop novel inhibitors of ENL-YEATS for the treatment of acute leukemias such as Acute Myelogenous Leukemia (AML) and potentially solid tumors.

Therapeutics, Inc. (NASDAQ: PTCT) today announced that Marcio Souza , Chief Operating Officer, has resigned and will be leaving the company by April 25 th , 2020.